Cargando…
OncomiR miR-182-5p Enhances Radiosensitivity by Inhibiting the Radiation-Induced Antioxidant Effect through SESN2 in Head and Neck Cancer
Radiotherapy is routinely used for the treatment of head and neck squamous cell carcinoma (HNSCC). However, the therapeutic efficacy is usually reduced by acquired radioresistance and locoregional recurrence. In this study, The Cancer Genome Atlas (TCGA) analysis showed that radiotherapy upregulated...
Autores principales: | Lin, Min-Ying, Chang, Yu-Chan, Wang, Shan-Ying, Yang, Muh-Hwa, Chang, Chih-Hsien, Hsiao, Michael, Kitsis, Richard N., Lee, Yi-Jang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614815/ https://www.ncbi.nlm.nih.gov/pubmed/34829679 http://dx.doi.org/10.3390/antiox10111808 |
Ejemplares similares
-
OMCD: OncomiR Cancer Database
por: Sarver, Aaron L., et al.
Publicado: (2018) -
miR-128 Functions as an OncomiR for the Downregulation of HIC1 in Breast Cancer
por: Li, Yan, et al.
Publicado: (2019) -
OncomiR-17-5p: alarm signal in cancer?
por: Bobbili, Madhusudhan Reddy, et al.
Publicado: (2017) -
Two oncomiRs, miR-182-5p and miR-103a-3p, Involved in Intravenous Leiomyomatosis
por: Barnaś, Edyta, et al.
Publicado: (2023) -
A structural map of oncomiR-1 at single-nucleotide resolution
por: Chakraborty, Saikat, et al.
Publicado: (2017)